glp-1 compounding crackdown news october 2025 US signals on compounded weight-loss drugs; Hims shares tumble FDA declares upcoming crackdown on

Semaglutide produces average weight loss of 10-15% of body weight

Your doctor will generally look at three specific areas: Your Health Metrics: Your doctor assesses individual markers like blood sugar levels, body mass index (BMI), and metabolic health to determine the duration and intensity of treatment

Oral GLP-1s, such as oral semaglutide or tirzepatide are not as effective

It supports your bodys natural GLP-1 pathways, which can help with satiety, cravings, and metabolic balance - all of which can absolutely support your goals when paired with healthy habits.

Integrating GLP1s into a LiverFirst Treatment Strategy When considering GLP1 therapy for patients with liver complications linked to metabolic dysfunction, clinicians should assess both hepatic and metabolic status not just weight or A1C